RE: New website/logo/name/mission statement8 Jun 2021 09:38
As suspected, RENX are pushing on to the next level with new hires for comnercial partnerships and comms. New RNS shows they will start speaking with the numerous health trusts across the US. Expect RNX to push on beyond 1500p later this year.
Leadership additions announced to support expanding US Government and Healthcare Provider KidneyIntelX Deployment
Enabling expertise in sales, population health and value-driven care models
NEW YORK and SALT LAKE CITY, June 7, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announces a series of key hires to drive its commercialization strategy in the United States market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing and care model implementation in early-stage diabetic kidney disease populations. Renalytix expects to continue expanding its sales, marketing, and implementation teams with expected KidneyIntelX roll-out beginning in the VA Medical Health System in the 2nd half of 2021, and as the Company positions for a broader national expansion beginning in fiscal 2022 in line with expectations for a national Medicare insurance coverage determination later this year.